The popularity of Sildenafil initially fueled a surge for the drug industry, nevertheless recent developments present a uncertain outlook for read more those considering a stake. Generic versions are reducing earnings, and persistent legal battles add more difficulty to the equation. While certain companies could still benefit from adjacent service